Itโs a dark time in the struggle with the coronavirus, particularly in the United States, where infections and hospitalizations have surged.
But amid the gloom comes some light: A trial by the drug maker Pfizer has returned preliminary results suggesting that its vaccine is 90 percent effective in preventing Covid-19.
With the virus raging, how strong is this new ray of hope?
Guest: Carl Zimmer, a science writer and author of the โMatterโ column for The New York Times.
Background reading:
We want to hear from you. Fill out our survey about this show and others at nytimes.com/thedailysurvey.
๐ 2020-11-11 11:55 / โ 00:30:19
๐ 2020-11-10 11:55 / โ 00:33:47
๐ 2020-11-09 11:55 / โ 00:39:14
๐ 2020-11-08 15:00 / โ 00:59:27
๐ 2020-11-07 23:10 / โ 00:37:11